EPO: Orphan Designation
Given protection to Amgen against competitors
EPO has been marketed at a premium price
Notes:
Levinsky, Norman G. The Organization Of Medical Care -- Lessons from the Medicare End Stage Renal Disease Program. [Article] New England Journal of Medicine. 329(19):1395-1399, Nov 4, 1993.